Spero Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Spero Therapeutics Inc
TickerSPRO
CIK #0001701108
CUSIP84833T103
SectorLife Sciences - Pharmaceutical Preparations
Address675 Massachusetts Avenue 14th Floor, Cambridge, MA 02139
Source [EDGAR]
CIK Filing 2011 - 2025
[0001701108] 10-K
[0001701108] 10-Q
[0001701108] 3
[0001701108] 4
[0001701108] 8-K
[0001701108] D
[0001701108] SC 13D
[0001701108] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Anson Funds Management LP Spero Therapeutics Inc [2024-02-14] 81948.1
BlackRock Inc Spero Therapeutics Inc [2022-07-08] 2.1
Pfizer Inc Spero Therapeutics Inc [2021-07-09] 7.37
BlackRock Inc Spero Therapeutics Inc [2021-02-02] 6.4
Atlas Venture Fund X LP Spero Therapeutics Inc [2018-03-14] 7.2
RA Capital Management LLC Spero Therapeutics Inc [2018-02-14] 8.5
Lundbeckfond Invest A/S Spero Therapeutics Inc [2018-02-14] 7.6
GV 2015 LP Spero Therapeutics Inc [2018-02-14] 7.7
Atlas Venture Associates IX LP Spero Therapeutics Inc [2018-02-13] 0.58
FMR LLC Spero Therapeutics Inc [2018-02-13] 0.0
GlaxoSmithKline PLC Spero Therapeutics Inc [2017-11-16] 13.3
Merck & Co Inc Spero Therapeutics Inc [2017-11-15] 6.5
Biotechnology Value Fund L P Spero Therapeutics Inc [2017-11-09] 3.7
Form 3/4/5 Filer 2011 - 2025
Pottage John C Jr
Spero Therapeutics, Inc.
Tregoning Kathleen
Thomas Frank E
Smith Cynthia
Mahadevia Ankit
Deshpande Milind
Jackson Scott Thomas
VINK Patrick VJJ
Rajavelu Esther
Keutzer Timothy
Shukla Sath
Joseph Tamara L
Hamed Kamal
DiPalma Stephen J.
GSK plc
Aquilo Capital Management, LLC
Aquilo Capital, L.P.
Melnick David A.
Larkin Cristina
Formela Jean Francois
Parr Thomas R JR
Sendek Joel
Southwell David P
Breum Casper
Goyal Vikas
Halse Reza
Atlas Venture Associates IX, L.P.
Atlas Venture Fund IX, L.P.
Atlas Venture Associates IX, LLC
Lundbeckfond Invest A/S
GV 2015 LP
GV 2015 GP LLC
Alphabet Inc.
Form 13F Holdings
Firm Period DFND Voting Shares
Pfizer Inc [2025-06-30] SOLE 2,362,348 2,362,348
Vanguard Group Inc [2025-06-30] SOLE 0 1,940,219
Anson Funds Management LP [2025-06-30] DFND 1,615,469 1,615,469
Alphabet Inc. [2025-06-30] DFND 0 889,979
Renaissance Technologies LLC [2025-06-30] SOLE 832,165 832,165
Schonfeld Strategic Advisors LLC [2025-06-30] SOLE 510,834 510,834
Geode Capital Management LLC [2025-06-30] DFND 510,699 510,699
BlackRock, Inc. [2025-06-30] SOLE 433,897 434,768
Monimus Capital Management LP [2025-06-30] SOLE 310,908 310,908
Citadel Advisors LLC [2025-06-30] DFND 240,986 240,986
Informed Momentum Co LLC [2025-06-30] SOLE 239,140 239,140
Stonepine Capital Management LLC [2025-06-30] SOLE 156,888 156,888
State Street Corp [2025-06-30] DFND 153,451 153,451
Ionic Capital Management LLC [2025-06-30] DFND 150,000 150,000
Adar1 Capital Management LLC [2025-06-30] SOLE 143,917 143,917
Susquehanna International Group LLP [2025-06-30] OTR 69,814 118,514
Bridgeway Capital Management LLC [2025-06-30] SOLE 114,800 114,800
Acadian Asset Management LLC [2025-06-30] DFND 112,889 112,889
Northern Trust Corp [2025-06-30] DFND 100,831 100,831
XTX Topco Ltd [2025-06-30] DFND 34,551 34,551
Capital Asset Advisory Services LLC [2025-06-30] SOLE 0 32,548
Axxcess Wealth Management LLC [2025-06-30] SOLE 0 32,548
Quadrature Capital Ltd [2025-06-30] OTR 0 31,205
Simplex Trading LLC [2025-06-30] SOLE 30,322 30,322
Three Seasons Wealth, LLC [2025-06-30] SOLE 30,000 30,000
Charles Schwab Investment Management Inc [2025-06-30] SOLE 28,565 28,565
Cubist Systematic Strategies, LLC [2025-06-30] DFND 0 27,140
Invesco Ltd. [2025-06-30] DFND 0 14,968
Vanguard Group Inc [2025-06-30] DFND 0 10,162
Texas Yale Capital Corp [2025-06-30] SOLE 10,000 10,000
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com